TY - JOUR
T1 - Understanding racial disparities in gastrointestinal cancer outcomes
T2 - Lack of surgery contributes to lower survival in African American patients
AU - Bliton, John N.
AU - Parides, Michael
AU - Muscarella, Peter
AU - Papalezova, Katia T.
AU - In, Haejin
N1 - Funding Information:
Effort by H. In was supported by NIH-NCI grant 2K12 CA132783-06 (Paul Calabresi Career Development Award) and NIH-NCI grant 2UG1CA189859-06 (Minority-Based Community Oncology Research Program). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Publisher Copyright:
©2020 American Association for Cancer Research.
PY - 2021/3
Y1 - 2021/3
N2 - Background: Race/ethnicity-related differences in rates of cancer surgery and cancer mortality have been observed for gastrointestinal (GI) cancers. This study aims to estimate the extent to which differences in receipt of surgery explain racial/ethnic disparities in cancer survival. Methods: The National Cancer Database was used to obtain data for patients diagnosed with stage I–III mid-esophageal, distal esophagus/gastric cardia (DEGC), noncardia gastric, pancreatic, and colorectal cancer in years 2004–2015. Mediation analysis was used to identify variables influencing the relationship between race/ ethnicity and mortality, including surgery. Results: A total of 600,063 patients were included in the study: 3.5% mid-esophageal, 12.4% DEGC, 4.9% noncardia gastric, 17.0% pancreatic, 40.1% colon, and 22.0% rectal cancers. The operative rates for Black patients were low relative to White patients, with absolute differences of 21.0%, 19.9%, 2.3%, 8.3%, 1.6%, and 7.7%. Adjustment for age, stage, and comorbidities revealed even lower odds of receiving surgery for Black patients compared with White patients. The observed HRs for Black patients compared with White patients ranged from 1.01 to 1.42. Mediation analysis showed that receipt of surgery and socioeconomic factors had greatest influence on the survival disparity. Conclusions: The results of this study indicate that Black patients appear to be undertreated compared with White patients for GI cancers. The disproportionately low operative rates contribute to the known survival disparity between Black and White patients. Impact: Interventions to reduce barriers to surgery for Black patients should be promoted to reduce disparities in GI cancer outcomes.
AB - Background: Race/ethnicity-related differences in rates of cancer surgery and cancer mortality have been observed for gastrointestinal (GI) cancers. This study aims to estimate the extent to which differences in receipt of surgery explain racial/ethnic disparities in cancer survival. Methods: The National Cancer Database was used to obtain data for patients diagnosed with stage I–III mid-esophageal, distal esophagus/gastric cardia (DEGC), noncardia gastric, pancreatic, and colorectal cancer in years 2004–2015. Mediation analysis was used to identify variables influencing the relationship between race/ ethnicity and mortality, including surgery. Results: A total of 600,063 patients were included in the study: 3.5% mid-esophageal, 12.4% DEGC, 4.9% noncardia gastric, 17.0% pancreatic, 40.1% colon, and 22.0% rectal cancers. The operative rates for Black patients were low relative to White patients, with absolute differences of 21.0%, 19.9%, 2.3%, 8.3%, 1.6%, and 7.7%. Adjustment for age, stage, and comorbidities revealed even lower odds of receiving surgery for Black patients compared with White patients. The observed HRs for Black patients compared with White patients ranged from 1.01 to 1.42. Mediation analysis showed that receipt of surgery and socioeconomic factors had greatest influence on the survival disparity. Conclusions: The results of this study indicate that Black patients appear to be undertreated compared with White patients for GI cancers. The disproportionately low operative rates contribute to the known survival disparity between Black and White patients. Impact: Interventions to reduce barriers to surgery for Black patients should be promoted to reduce disparities in GI cancer outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85102112363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102112363&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-20-0950
DO - 10.1158/1055-9965.EPI-20-0950
M3 - Article
C2 - 33303644
AN - SCOPUS:85102112363
SN - 1055-9965
VL - 30
SP - 529
EP - 538
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 3
ER -